ArticleNature communications2024

Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade.

Panayiotis Anastasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.